Utah Retirement Systems’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$23.8M Sell
188,623
-13,859
-7% -$1.83M 0.23% 74
2026
Q1
$28.2M Sell
202,482
-3,335
-2% -$467K 0.29% 59
2025
Q4
$25.3M Hold
205,817
0.24% 77
2025
Q3
$22.8M Buy
205,817
+173
+0.1% +$19.7K 0.22% 87
2025
Q2
$22.8M Sell
205,644
-1,087
-0.5% -$116K 0.24% 79
2025
Q1
$23.2M Sell
206,731
-320
-0.2% -$33K 0.27% 69
2024
Q4
$19.1M Buy
207,051
+600
+0.3% +$54K 0.21% 86
2024
Q3
$17.3M Buy
206,451
+800
+0.4% +$61K 0.2% 101
2024
Q2
$14.1M Sell
205,651
-11,100
-5% -$741K 0.17% 113
2024
Q1
$15.9M Sell
216,751
-100
-0% -$7.69K 0.19% 110
2023
Q4
$17.6M Buy
216,851
+1,800
+0.8% +$140K 0.22% 91
2023
Q3
$16.1M Buy
215,051
+500
+0.2% +$38.5K 0.23% 88
2023
Q2
$16.5M Sell
214,551
-9,100
-4% -$726K 0.23% 88
2023
Q1
$18.6M Buy
223,651
+641
+0.3% +$53.1K 0.27% 77
2022
Q4
$19.1M Sell
223,010
-2,100
-0.9% -$166K 0.3% 74
2022
Q3
$13.9M Buy
225,110
+1,500
+0.7% +$94.6K 0.23% 85
2022
Q2
$13.8M Sell
223,610
-400
-0.2% -$24.8K 0.22% 90
2022
Q1
$13.3M Sell
224,010
-3,800
-2% -$243K 0.18% 109
2021
Q4
$16.5M Buy
227,810
+500
+0.2% +$34.4K 0.2% 95
2021
Q3
$15.9M Sell
227,310
-12,000
-5% -$843K 0.21% 93
2021
Q2
$16.5M Sell
239,310
-1,900
-0.8% -$127K 0.21% 96
2021
Q1
$15.6M Sell
241,210
-10,700
-4% -$690K 0.22% 97
2020
Q4
$14.7M Buy
251,910
+10,900
+5% +$658K 0.21% 98
2020
Q3
$15.2M Buy
241,010
+1,600
+0.7% +$111K 0.25% 81
2020
Q2
$18.4M Sell
239,410
-4,000
-2% -$307K 0.34% 61
2020
Q1
$18.2M Hold
243,410
0.39% 54
2019
Q4
$15.8M Buy
243,410
+900
+0.4% +$58.6K 0.28% 73
2019
Q3
$15.4M Buy
242,510
+1,000
+0.4% +$65.4K 0.29% 70
2019
Q2
$16.3M Buy
241,510
+436
+0.2% +$28.7K 0.31% 65
2019
Q1
$15.7M Sell
241,074
-312
-0.1% -$20.7K 0.31% 64
2018
Q4
$15.1M Buy
241,386
+500
+0.2% +$34.9K 0.34% 63
2018
Q3
$18.6M Buy
240,886
+1,100
+0.5% +$83.1K 0.36% 59
2018
Q2
$17M Sell
239,786
-2,700
-1% -$191K 0.35% 58
2018
Q1
$18.3M Buy
242,486
+400
+0.2% +$31.8K 0.39% 52
2017
Q4
$17.3M Buy
242,086
+3,400
+1% +$258K 0.36% 54
2017
Q3
$19.3M Buy
238,686
+200
+0.1% +$15.3K 0.43% 45
2017
Q2
$16.9M Sell
238,486
-4,400
-2% -$293K 0.39% 46
2017
Q1
$16.5M Buy
242,886
+200
+0.1% +$14.1K 0.39% 46
2016
Q4
$17.4M Sell
242,686
-100
-0% -$7.43K 0.44% 44
2016
Q3
$19.2M Buy
242,786
+100
+0% +$8.12K 0.5% 38
2016
Q2
$20.2M Sell
242,686
-7,400
-3% -$657K 0.54% 37
2016
Q1
$23M Sell
250,086
-13,500
-5% -$1.22M 0.62% 31
2015
Q4
$26.7M Buy
263,586
+400
+0.2% +$41.6K 0.72% 26
2015
Q3
$25.8M Buy
263,186
+1,400
+0.5% +$155K 0.74% 22
2015
Q2
$30.6M Sell
261,786
-12,900
-5% -$1.41M 0.81% 18
2015
Q1
$27M Buy
274,686
+8,900
+3% +$904K 0.71% 24
2014
Q4
$25.1M Hold
265,786
0.69% 25
2014
Q3
$28.3M Sell
265,786
-600
-0.2% -$58.8K 0.81% 20
2014
Q2
$22.1M Sell
266,386
-7,600
-3% -$592K 0.63% 29
2014
Q1
$19.4M Buy
273,986
+2,000
+0.7% +$157K 0.56% 33
2013
Q4
$20.4M Hold
271,986
0.6% 33
2013
Q3
$17.1M Sell
271,986
-2,400
-0.9% -$143K 0.55% 35
2013
Q2
$14.1M Buy
+274,386
New +$14.3M 0.47% 35

Other funds holding GILD

Utah Retirement Systems's GILD Position: Q2 2026 in Review

Utah Retirement Systems reduced its Gilead Sciences (GILD) stake by 6.8% in Q2 2026, selling an estimated $1.83M and leaving 188,623 shares worth $23.8M. The position accounts for 0.23% of the portfolio, ranked #74.

Utah Retirement Systems first reported a position in GILD in Q2 2013 and has held it in 53 quarters since. The position peaked at $30.6M in Q2 2015. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Utah Retirement Systems held 188,623 shares of Gilead Sciences worth $23.8M as of Q2 2026.
  • Utah Retirement Systems sold 13,859 Gilead Sciences shares in Q2 2026, an estimated $1.83M.
  • Gilead Sciences made up 0.23% of Utah Retirement Systems's portfolio in Q2 2026, its #74 holding.
  • Utah Retirement Systems first reported a position in Gilead Sciences in Q2 2013 and has held it in 53 quarters since.
  • Utah Retirement Systems's Gilead Sciences position peaked at $30.6M in Q2 2015.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Utah Retirement Systems's 13F filing for Q2 2026, filed 14 Aug 2026.